December 2022 at a glance: heart failure with preserved ejection fraction, sodium-glucose cotransporter 2 inhibitors and cardiac amyloidosis

Eur J Heart Fail. 2022 Dec;24(12):2209-2211. doi: 10.1002/ejhf.2244.

Authors

Daniela Tomasoni¹, Marianna Adamo¹, Marco Metra¹

Affiliation

¹ Cardiology and Cardiac Catheterization Laboratory, Cardio-Thoracic Department, Civil Hospitals; Department of Medical and Surgical Specialties, Radiological Sciences, and Public Health, University of Brescia, Brescia, Italy.

PMID: 36575134
DOI: 10.1002/ejhf.2244

No abstract available

MeSH terms

Amyloidosis* / drug therapy
Heart Failure* / drug therapy
Humans
Sodium-Glucose Transporter 2 Inhibitors* / therapeutic use
Stroke Volume

Substances

Sodium-Glucose Transporter 2 Inhibitors